Post
AstraZeneca posts $2.18bn profit after tax in Q1 2024
AstraZeneca has reported profit after tax of $2.18bn for the first quarter (Q1) of 2024, a notable rise from $1.80bn …
Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
Senator Bernie Sanders has targeted the high drug prices of Novo Nordisk’s Ozempic and Wegovy, revealing that the Senate Committee …
Cidara buys back rights to flu therapy from J&J for $85m
Cidara Therapeutics has entered into a definitive agreement with Johnson & Johnson (J&) to buy back the rights to its …
Inflation Reduction Act to have knock on effect on R&D, say biotech experts
Discussions surrounding the Inflation Reduction Act (IRA) are heating up as the 2026 effect date gets closer. Speakers at the …
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them …
Merck plans €300m investment at new German research centre
Merck KGaA (Merck) has announced an investment of more than €300m ($320.8m) in a new Life Science Research Center at …
Mundipharma to acquire rezafungin assets from Cidara Therapeutics
Mundipharma has signed an agreement to acquire all assets and rights related to antifungal candidate Rezzayo (rezafungin) from Cidara Therapeutics, …
Life science SMEs “heading out of the funding winter”
After what has been deemed a “funding winter” for life science SMEs, building a strong data package to attract larger …
Biogen reports net income of $393.4m in Q1 2024
Biogen has reported net income of $393.4m for the first quarter (Q1) of 2024, an increase from $387.6m in the …
FDA approves Utility Therapeutics’ Pivya tablets for UTIs
The US Food and Drug Administration (FDA) has approved Utility Therapeutics’ Pivya tablets, a new treatment for female adults with …
Investors anticipate “bounce-back” in European private investment
The Swiss biotech ecosystem suffers from a “weak public market”, said Francesco de Rubertis, a cofounder at Medicxi Ventures. Despite …
Novartis bags paediatric FDA label expansion for Lutathera
Novartis has received a US Food and Drug Administration (FDA) approval for the label expansion of its peptide receptor radionuclide …
Johnson & Johnson gets grant for heart ultrasound image selection based on physiological cycle
Johnson & Johnson's patented method involves using ultrasound frames to assess heart function. The system processes signals tracking physiological cycles …
Pfizer gets grant for treatment of cancer using engineered immune cells targeting bcma
Pfizer has patented CARs that target BCMA for treating conditions related to malignant cells expressing BCMA, like cancer. The method …
Bicycle Therapeutics gets grant for high affinity binders of nectin-4 for treating diseases
Bicycle Therapeutics has been granted a patent for polypeptides covalently bound to molecular scaffolds, specifically high affinity binders of Nectin-4. …